Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lehmann

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|August 6, 2003
Is there standard chemotherapy for metastatic bladder cancer? Quality of life and medical resources utilization based on largest to date randomized trialJan Lehmann, Margitta Retz, Michael Stöckle
World Journal of Urology|August 28, 2002
Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapyJan Lehmann, Margitta Retz, Michael Stöckle
BJU International|November 6, 2007
Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissectionHenrik Suttmann, Jörn Kamradt, Jan Lehmann, et al.
BJU International|November 6, 2007
Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapyHenrik Suttmann, Jörn Kamradt, Jan Lehmann, et al.
BJU International|December 13, 2005
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancerJan Lehmann, Ludger Franzaring, Joachim Thüroff, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 10, 2023
Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims AnalysisNadia Quignot, Heng Jiang, Indraraj Umesh Doobaree, et al.
World Journal of Urology|January 27, 2005
Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesionsTillmann Loch, Ursula Eppelmann, Jan Lehmann, et al.
Expert Review of Anticancer Therapy|December 31, 2002
Managing locally advanced bladder cancerJan Lehmann, Margitta Retz, Stefan Siemer, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinomaJan Lehmann, Margitta Retz, Stefan Siemer, et al.
The Journal of Urology|February 10, 2004
Lymph node positive prostate cancer: long-term survival data after radical prostatectomyUlrike Zwergel, Jan Lehmann, Bernd Wullich, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|August 6, 2003
Is there standard chemotherapy for metastatic bladder cancer? Quality of life and medical resources utilization based on largest to date randomized trialJan Lehmann, Margitta Retz, Michael Stöckle
World Journal of Urology|August 28, 2002
Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapyJan Lehmann, Margitta Retz, Michael Stöckle
BJU International|November 6, 2007
Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissectionHenrik Suttmann, Jörn Kamradt, Jan Lehmann, et al.
BJU International|November 6, 2007
Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapyHenrik Suttmann, Jörn Kamradt, Jan Lehmann, et al.
BJU International|December 13, 2005
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancerJan Lehmann, Ludger Franzaring, Joachim Thüroff, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 10, 2023
Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims AnalysisNadia Quignot, Heng Jiang, Indraraj Umesh Doobaree, et al.
World Journal of Urology|January 27, 2005
Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesionsTillmann Loch, Ursula Eppelmann, Jan Lehmann, et al.
Expert Review of Anticancer Therapy|December 31, 2002
Managing locally advanced bladder cancerJan Lehmann, Margitta Retz, Stefan Siemer, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinomaJan Lehmann, Margitta Retz, Stefan Siemer, et al.
The Journal of Urology|February 10, 2004
Lymph node positive prostate cancer: long-term survival data after radical prostatectomyUlrike Zwergel, Jan Lehmann, Bernd Wullich, et al.
Pageof 6